Hidehiko Narazaki

786 total citations
21 papers, 462 citations indexed

About

Hidehiko Narazaki is a scholar working on Immunology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Hidehiko Narazaki has authored 21 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Hematology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hidehiko Narazaki's work include Immune Cell Function and Interaction (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and T-cell and B-cell Immunology (4 papers). Hidehiko Narazaki is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and T-cell and B-cell Immunology (4 papers). Hidehiko Narazaki collaborates with scholars based in Japan, United States and China. Hidehiko Narazaki's co-authors include Lieping Chen, Fumihiko Tsushima, Atsuo Kuramasu, Ryusuke Omiya, Koji Tamada, Yukimi Sakoda, Scott E. Strome, Jang‐June Park, Yumiko Matsumura and Sheng Yao and has published in prestigious journals such as Blood, The Journal of Immunology and Immunology.

In The Last Decade

Hidehiko Narazaki

15 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hidehiko Narazaki Japan 8 314 261 49 42 30 21 462
Samuel O’Connell United Kingdom 4 359 1.1× 300 1.1× 79 1.6× 29 0.7× 24 0.8× 4 497
Katherine A. Waugh United States 7 248 0.8× 215 0.8× 68 1.4× 49 1.2× 20 0.7× 16 423
José R. Vilchez Spain 9 213 0.7× 106 0.4× 42 0.9× 59 1.4× 47 1.6× 15 350
Fréderic Vély France 5 549 1.7× 250 1.0× 98 2.0× 21 0.5× 60 2.0× 5 654
Juhi R. Kuchroo United States 7 347 1.1× 232 0.9× 79 1.6× 20 0.5× 29 1.0× 9 466
Anna Szaflarska Poland 10 247 0.8× 71 0.3× 49 1.0× 46 1.1× 34 1.1× 25 353
Jasper J. P. van Beek Netherlands 10 187 0.6× 158 0.6× 70 1.4× 31 0.7× 24 0.8× 10 332
Hai Hong China 11 181 0.6× 125 0.5× 88 1.8× 26 0.6× 21 0.7× 15 304
Alvaro Moreira Germany 11 207 0.7× 342 1.3× 124 2.5× 96 2.3× 67 2.2× 25 573
Sean J. Judge United States 11 349 1.1× 272 1.0× 64 1.3× 94 2.2× 31 1.0× 37 503

Countries citing papers authored by Hidehiko Narazaki

Since Specialization
Citations

This map shows the geographic impact of Hidehiko Narazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidehiko Narazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidehiko Narazaki more than expected).

Fields of papers citing papers by Hidehiko Narazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidehiko Narazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidehiko Narazaki. The network helps show where Hidehiko Narazaki may publish in the future.

Co-authorship network of co-authors of Hidehiko Narazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Hidehiko Narazaki. A scholar is included among the top collaborators of Hidehiko Narazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidehiko Narazaki. Hidehiko Narazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimizu, Masaki, Eisuke Inoue, Ryoko Sakai, et al.. (2025). Verification of unmet medical needs in patients with juvenile idiopathic arthritis in Japan. Modern Rheumatology. 35(5). 909–915.
2.
Wakiguchi, Hiroyuki, Utako Kaneko, Satoshi Sato, et al.. (2023). Clinical Features of COVID-19 in Pediatric Rheumatic Diseases: 2020–2022 Survey of the Pediatric Rheumatology Association of Japan. Viruses. 15(5). 1205–1205. 4 indexed citations
3.
Kishi, Takayuki, Naoko Nakano, Hidehiko Narazaki, et al.. (2023). Survey of diversity awareness and environment among members of the Pediatric Rheumatology Association of Japan. Pediatrics International. 65(1). e15654–e15654.
4.
Narazaki, Hidehiko. (2022). Current Status of Pediatric Rheumatic Disease Care in Japan. 18(3). 274–281.
5.
Yamanishi, Shingo, Makoto Watanabe, Hidehiko Narazaki, et al.. (2022). A case of seronegative primary Sjögren’s syndrome complicated by Takayasu arteritis in a Japanese girl. Modern Rheumatology Case Reports. 7(1). 148–153.
6.
Fujita, Atsushi, et al.. (2021). Drug resistance to nelarabine in leukemia cell lines might be caused by reduced expression of deoxycytidine kinase through epigenetic mechanisms. Cancer Chemotherapy and Pharmacology. 89(1). 83–91. 4 indexed citations
7.
Wakabayashi, Mako, et al.. (2020). Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host–environmental interactions. Current Opinion in Allergy and Clinical Immunology. 21(1). 1–7. 15 indexed citations
8.
9.
Asano, Takeshi, Hidehiko Narazaki, & Atsushi Fujita. (2016). Genome-wide DNA methylation profiling of CpG islands in a morpholino anthracycline derivative-resistant leukemia cell line: p38αas a novel candidate for resistance. Pharmacology Research & Perspectives. 5(1). e00285–e00285. 4 indexed citations
10.
Asano, Takeshi, et al.. (2015). Seronegative Antiphospholipid Syndrome with Anti-phosphatidylethanolamine Antibody in a Boy. Journal of Nippon Medical School. 82(2). 117–120. 3 indexed citations
11.
Koizumi, Shinya, Hidehiko Narazaki, Takeshi Asano, et al.. (2015). Clinical Pictures in Pelizaeus-Merzbacher Disease: A Report of a Case. Journal of Nippon Medical School. 82(2). 74–75. 3 indexed citations
12.
Asano, Takeshi, et al.. (2015). Neglect‐induced pseudo‐thrombotic thrombocytopenic purpura due to vitamin B12 deficiency. Pediatrics International. 57(5). 988–990. 9 indexed citations
13.
Narazaki, Hidehiko, et al.. (2014). Melatonin overcomes resistance to clofarabine in two leukemic cell lines by increased expression of deoxycytidine kinase. Experimental Hematology. 43(3). 207–214. 21 indexed citations
14.
Narazaki, Hidehiko, et al.. (2012). Delayed-type Hypersensitivity in Response to L-asparaginase in a Case of Acute Lymphoblastic Leukemia. Journal of Nippon Medical School. 79(6). 489–493. 3 indexed citations
15.
Park, Jang‐June, Ryusuke Omiya, Yumiko Matsumura, et al.. (2010). B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance. Blood. 116(8). 1291–1298. 266 indexed citations
16.
Narazaki, Hidehiko, Yuwen Zhu, Liqun Luo, Gefeng Zhu, & Lieping Chen. (2010). CD137 agonist antibody prevents cancer recurrence: contribution of CD137 on both hematopoietic and nonhematopoietic cells. Blood. 115(10). 1941–1948. 38 indexed citations
17.
Omiya, Ryusuke, Fumihiko Tsushima, Hidehiko Narazaki, et al.. (2009). Leucocyte‐associated immunoglobulin‐like receptor‐1 is an inhibitory regulator of contact hypersensitivity. Immunology. 128(4). 543–555. 16 indexed citations
18.
Maeda, Miho, Yoshitaka Fukunaga, Takeshi Asano, et al.. (2005). Clinical Aspects of Infant Leukemia-Experiences of a Single Institution of Japan: High Level of Serum Immunoglobulin M in Infant Leukemia. Journal of Nippon Medical School. 72(6). 355–363. 1 indexed citations
19.
Norose, Yoshihiko, Yoshiyuki Watanabe, Yutaka Enomoto, et al.. (2003). Cutting Edge: Major CD8 T Cell Response to Live Bacillus Calmette-Guerin Is Mediated by CD1 Molecules. The Journal of Immunology. 170(11). 5345–5348. 60 indexed citations
20.
Narazaki, Hidehiko, Eiji Watari, Masumi Shimizu, et al.. (2003). Perforin-dependent killing of tumor cells by Vγ1Vδ1-bearing T-cells. Immunology Letters. 86(1). 113–119. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samuel O’Connell Breakdown of academic impact, for papers by Katherine A. Waugh Breakdown of academic impact, for papers by José R. Vilchez Breakdown of academic impact, for papers by Fréderic Vély Breakdown of academic impact, for papers by Juhi R. Kuchroo Breakdown of academic impact, for papers by Anna Szaflarska Breakdown of academic impact, for papers by Jasper J. P. van Beek Breakdown of academic impact, for papers by Hai Hong Breakdown of academic impact, for papers by Alvaro Moreira Breakdown of academic impact, for papers by Sean J. Judge
Rankless by CCL
2026